Check-Cap Ltd. (CHEK)
NASDAQ: CHEK · IEX Real-Time Price · USD
2.030
+0.020 (1.00%)
At close: Jul 19, 2024, 4:00 PM
2.070
+0.040 (1.97%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Company Description
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel.
Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient’s back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.
The company was incorporated in 2004 and is based in Isfiya, Israel.
Check-Cap Ltd.
| Country | Israel |
| Founded | 2004 |
| IPO Date | Feb 19, 2015 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 85 |
| CEO | Saar Levi |
Contact Details
Address: Abba Hushi Avenue, P.o. Box 1271 Isfiya, L3 3009000 Israel | |
| Phone | 972-4-8303400 |
| Website | check-cap.com |
Stock Details
| Ticker Symbol | CHEK |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001610590 |
| CUSIP Number | M2361E203 |
| ISIN Number | IL0011336851 |
| SIC Code | 3844 |
Key Executives
| Name | Position |
|---|---|
| Alex Ovadia | Chief Executive Officer and Director |
| Dr. Yoav Kimchy Ph.D. | Founder and Interim Chief Technology Officer |
| Joshua Belkar | Vice President of Operations |
| Iris Even-Tov | Interim Chief Financial Officer |
| Noa Reshef M.B.A. | Director of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 15, 2024 | 20-F | Annual and transition report of foreign private issuers |
| May 1, 2024 | NT 20-F | Notification of inability to timely file Form 20-F |
| Apr 29, 2024 | 6-K | Report of foreign issuer |
| Apr 15, 2024 | 6-K | Report of foreign issuer |
| Apr 10, 2024 | 6-K/A | Filing |
| Apr 8, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Apr 8, 2024 | 6-K | Report of foreign issuer |
| Apr 5, 2024 | 6-K | Report of foreign issuer |
| Apr 1, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Mar 28, 2024 | 6-K | Report of foreign issuer |